Literature DB >> 12827529

Prevalence of group B streptococcal type VI capsular IgG antibodies in Japan.

K Matsubara1, K Katayama, K Baba, H Nigami, H Harigaya.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12827529     DOI： 10.1007/s10096-003-0942-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  9 in total

1.  Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate.

Authors:  H D Davies; C Adair; A McGeer; D Ma; S Robertson; M Mucenski; L Kowalsky; G Tyrell; C J Baker
Journal:  J Infect Dis       Date:  2001-06-26       Impact factor: 5.226

2.  Seroepidemiology of group B streptococcus type III colonization at delivery.

Authors:  B M Gray; D G Pritchard; H C Dillon
Journal:  J Infect Dis       Date:  1989-06       Impact factor: 5.226

3.  Seroepidemiological studies of group B Streptococcus type II.

Authors:  B M Gray; D G Pritchard; H C Dillon
Journal:  J Infect Dis       Date:  1985-06       Impact factor: 5.226

Review 4.  Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development.

Authors:  A Schuchat; J D Wenger
Journal:  Epidemiol Rev       Date:  1994       Impact factor: 6.222

5.  Nontypable group B streptococci isolated from human sources.

Authors:  H W Wilkinson
Journal:  J Clin Microbiol       Date:  1977-08       Impact factor: 5.948

6.  Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII.

Authors:  L C Paoletti; J Pinel; K D Johnson; B Reinap; R A Ross; D L Kasper
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

7.  Prevalence of anti-group B streptococcal type III capsular IgG antibodies in the United Kingdom and an analysis of their specific IgG subclasses.

Authors:  R G Feldman; A Ferrante
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

8.  Change of antimicrobial susceptibility of group B streptococci over 15 years in Japan.

Authors:  K Matsubara; Y Nishiyama; K Katayama; G Yamamoto; M Sugiyama; T Murai; K Baba
Journal:  J Antimicrob Chemother       Date:  2001-10       Impact factor: 5.790

9.  Seroepidemiologic studies of serotype VIII group B Streptococcus in Japan.

Authors:  Kousaku Matsubara; Kazuaki Katayama; Kunizo Baba; Hiroyuki Nigami; Hidekazu Harigaya; Masako Sugiyama
Journal:  J Infect Dis       Date:  2002-08-16       Impact factor: 5.226
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.